Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

EphA4-dependent axon guidance is mediated by the RacGAP alpha2-chimaerin.

Neuron | Sep 6, 2007

http://www.ncbi.nlm.nih.gov/pubmed/17785182

Neuronal network formation in the developing nervous system is dependent on the accurate navigation of nerve cell axons and dendrites, which is controlled by attractive and repulsive guidance cues. Ephrins and their cognate Eph receptors mediate many repulsive axonal guidance decisions by intercellular interactions resulting in growth cone collapse and axon retraction of the Eph-presenting neuron. We show that the Rac-specific GTPase-activating protein alpha2-chimaerin binds activated EphA4 and mediates EphA4-triggered axonal growth cone collapse. alpha-Chimaerin mutant mice display a phenotype similar to that of EphA4 mutant mice, including aberrant midline axon guidance and defective spinal cord central pattern generator activity. Our results reveal an alpha-chimaerin-dependent signaling pathway downstream of EphA4, which is essential for axon guidance decisions and neuronal circuit formation in vivo.

Pubmed ID: 17785182 RIS Download

Mesh terms: Animals | Animals, Newborn | Brain | Cell Communication | Cell Differentiation | Cells, Cultured | Central Nervous System | Chimerin 1 | Down-Regulation | Gait Disorders, Neurologic | Gene Expression Regulation, Developmental | Growth Cones | Mice | Mice, Knockout | Neural Pathways | Protein Binding | Pyramidal Tracts | Receptor, EphA4 | Signal Transduction | Spinal Cord

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.